Simultaneous determination of Z-SU5416 and its interconvertible geometric E-isomer in rat plasma by LC/MS/MS
- J Pharm Biomed Anal. 2004 May 28;35(3):513-22. doi: 10.1016/j.jpba.2003.08.017.
- 1. Department of Bioanalysis, Metabolism and Phamacokinetics, SUGEN Inc., 230 E. Grand Ave., South San Francisco, CA 94080, USA.
SU5416 is a selective inhibitor of vascular endothelial growth factor (VEGF) receptor, which plays a major role in vascular angiogenesis. SU5416 exists as the thermodynamically stable and pharmacologically active cis isomer (Z-isomer) in the solid state. In light-exposed solutions the unstable trans isomer (E-isomer) is formed. The E-isomer is unstable for synthesis and isolation and the analytical standard of the E-isomer is unavailable. A new, simple, fast and reliable LC/MS/MS method was developed to quantify both isomers simultaneously in rat plasma samples in order to support the study of disposition kinetics of Z- and E-SU5416. This method is sensitive (LOQ = 0.5 ng/ml), reproducible, and has a wide linear range (0.5-2500 ng/ml).
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: VEGFR